 INmune Bio, Inc. NASDAQ:INMB Q3 2022 Results Conference Call November 2, 2022 4:30 PM ET Company Participants David Moss - Chief Financial Officer Dr. RJ Tesi - Chief Executive Officer Dr. CJ Barnum - Head of Neuroscience Dr. Mark Lowdell - Chief Scientific Officer Conference Call Participants Tom Shrader - BTIG Mayank Mamtani - B. Riley Securities Daniel Carlson - Tailwinds Research Operator Greetings, and welcome to the INmune Bio Third Quarter 2022 Earnings Call. 